Compare Manhattan Associates Inc (MANH) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Tenet Healthcare Corporation — how do they compare? Manhattan Associates Inc trades at $204.89 (market cap $12.06B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 376,150). Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and Tenet Healthcare Corporation for 15 Days on average.
| MANH | THC | |
|---|---|---|
Market Cap | $12.06B | $20.98B |
Volume | 376,150 | 428,008 |
Sector | Technology | Health |
52-Week High | $223.76 | $280.77 |
52-Week Low | $120.88 | $161.37 |
Typical Hold Time | 12 Days | 15 Days |
Enterprise Value | $11.93B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MANH trades at $206.78, up 2.31% today, with a bullish technical outlook as it sits above key support at $205. The company shows strong profitability with a net margin of 18.67% and has beaten earnings estimates for three consecutive quarters. Recent news includes a product launch of Editions for its solutions but also ongoing legal investigations into fiduciary duties.
The outlook is cautiously optimistic given analyst consensus of Buy and a $210.50 price target, though high valuation ratios and legal overhangs present risks. Earnings growth remains the key catalyst for further upside, but investors should weigh the elevated P/E of 59.26 against potential legal and competitive pressures.
Tenet Healthcare (THC) trades at $260.57, up 0.28% with strong technical momentum and bullish moving averages. The stock demonstrates robust fundamentals with consistent earnings beats, a 10.07 P/E ratio, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 earnings scheduled for October 29. Technical indicators show support at $257 and resistance at $262, with overall bullish sentiment from analysts.
THC presents a compelling investment case with strong profitability metrics and analyst consensus pointing to 8.7% upside to the $283.36 price target. Key risks include declining net cash flow and potential surgical volume pressures. The combination of value pricing, earnings momentum, and institutional support suggests continued upward potential, though investors should monitor cash flow sustainability and Q3 earnings results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
